Literature DB >> 8955268

Sensitization of meningeal sensory neurons and the origin of headaches.

A M Strassman1, S A Raymond, R Burstein.   

Abstract

The headaches that accompany certain intracranial pathologies (such as meningitis, subarachnoid haemorrhage and tumour) have been considered to result from mechanical or chemical stimulation of pain-sensitive structures of the intracranial meninges. Although the recurrent headache of migraine is of unknown origin and is not accompanied by an identifiable pathology, it shares with intracranial headaches features that suggest an exaggerated intracranial mechanosensitivity (worsening of the pain by coughing, breath-holding or sudden head movement). One possible basis for such symptoms would be a sensitization of meningeal afferents to mechanical stimuli. Previous studies of neuronal responses to meningeal stimulation have focused primarily on cells in the central portion of the trigeminal pathway, and have not investigated the possible occurrence of sensitization. We have recorded the activity of primary afferent neurons in the rat trigeminal ganglion that innervate the dural venous sinuses. Chemical stimulation of their dural receptive fields with inflammatory mediators both directly excited the neurons and enhanced their mechanical sensitivity, such that they were strongly activated by mechanical stimuli that initially had evoked little or no response. These properties of meningeal afferents (chemosensitivity and sensitization) may contribute to the intracranial mechanical hypersensitivity that is characteristic of some types of clinically occurring headaches, and may also contribute to the throbbing pain of migraine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955268     DOI: 10.1038/384560a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  198 in total

1.  Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP.

Authors:  Henrik Winther Schytz; Helle Holst; Lars Arendt-Nielsen; Jes Olesen; Messoud Ashina
Journal:  J Headache Pain       Date:  2010-05-09       Impact factor: 7.277

2.  Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine.

Authors:  Caterina Mainero; Jasmine Boshyan; Nouchine Hadjikhani
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

3.  Ionic mechanisms underlying inflammatory mediator-induced sensitization of dural afferents.

Authors:  Andrea H Vaughn; Michael S Gold
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 4.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

5.  Cold-sensitive corneal afferents respond to a variety of ocular stimuli central to tear production: implications for dry eye disease.

Authors:  Harumitsu Hirata; Ian D Meng
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-24       Impact factor: 4.799

Review 6.  Update on medication-overuse headache.

Authors:  Milena De Felice; Michael H Ossipov; Frank Porreca
Journal:  Curr Pain Headache Rep       Date:  2011-02

7.  Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.

Authors:  Paul L Durham; Caleb G Masterson
Journal:  Headache       Date:  2012-10-23       Impact factor: 5.887

Review 8.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

Review 9.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

10.  In child and adult migraineurs the somatosensory cortex stands out … again: An arterial spin labeling investigation.

Authors:  Andrew M Youssef; Allison Ludwick; Sophie L Wilcox; Alyssa Lebel; Ke Peng; Elisabeth Colon; Amy Danehy; Rami Burstein; Lino Becerra; David Borsook
Journal:  Hum Brain Mapp       Date:  2017-05-31       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.